JP2013501775A5 - - Google Patents

Download PDF

Info

Publication number
JP2013501775A5
JP2013501775A5 JP2012524330A JP2012524330A JP2013501775A5 JP 2013501775 A5 JP2013501775 A5 JP 2013501775A5 JP 2012524330 A JP2012524330 A JP 2012524330A JP 2012524330 A JP2012524330 A JP 2012524330A JP 2013501775 A5 JP2013501775 A5 JP 2013501775A5
Authority
JP
Japan
Prior art keywords
mycobacterium bovis
bovis bcg
composition
killed
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012524330A
Other languages
English (en)
Japanese (ja)
Other versions
JP5762407B2 (ja
JP2013501775A (ja
Filing date
Publication date
Priority claimed from EP09290627A external-priority patent/EP2292260A1/en
Application filed filed Critical
Publication of JP2013501775A publication Critical patent/JP2013501775A/ja
Publication of JP2013501775A5 publication Critical patent/JP2013501775A5/ja
Application granted granted Critical
Publication of JP5762407B2 publication Critical patent/JP5762407B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012524330A 2009-08-13 2010-08-12 アテローム性動脈硬化を予防又は治療するための、長期凍結乾燥(efd)により死滅したマイコバクテリウム・ボビスbcgの使用 Expired - Fee Related JP5762407B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09290627A EP2292260A1 (en) 2009-08-13 2009-08-13 Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
EP09290627.0 2009-08-13
PCT/IB2010/053652 WO2011018769A1 (en) 2009-08-13 2010-08-12 Use of mycobacterium bovis bcg killed by extended freeze drying (efd) for preventing or treating atherosclerosis

Publications (3)

Publication Number Publication Date
JP2013501775A JP2013501775A (ja) 2013-01-17
JP2013501775A5 true JP2013501775A5 (enExample) 2013-06-06
JP5762407B2 JP5762407B2 (ja) 2015-08-12

Family

ID=41402542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012524330A Expired - Fee Related JP5762407B2 (ja) 2009-08-13 2010-08-12 アテローム性動脈硬化を予防又は治療するための、長期凍結乾燥(efd)により死滅したマイコバクテリウム・ボビスbcgの使用

Country Status (7)

Country Link
US (1) US8414865B2 (enExample)
EP (2) EP2292260A1 (enExample)
JP (1) JP5762407B2 (enExample)
CA (1) CA2770915C (enExample)
DK (1) DK2464378T3 (enExample)
ES (1) ES2563577T3 (enExample)
WO (1) WO2011018769A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013106785B4 (de) 2013-06-28 2018-11-29 Pilz Auslandsbeteiligungen Gmbh Verfahren zur Synchronisation eines Lichtgitters und auf diesem Verfahren beruhendes Lichtgitter
KR102393711B1 (ko) 2013-10-17 2022-05-04 더 제너럴 하스피탈 코포레이션 자가면역 질환의 치료에 반응하는 대상체의 식별 방법 및 그의 치료를 위한 조성물
JP6628071B2 (ja) * 2015-04-28 2020-01-08 国立大学法人北海道大学 低密度リポタンパク質酸化抑制剤
US11266730B2 (en) * 2015-09-29 2022-03-08 The General Hospital Corporation Methods of treating and diagnosing disease using biomarkers for BCG therapy
US12491216B2 (en) 2018-12-04 2025-12-09 Neiker—Instituto Vasco De Investigacion Y Desarrollo Agrario, S.A. Immunostimulant for use against pathogens
CN120677168A (zh) * 2023-02-27 2025-09-19 明斯特威斯特法伦威廉大学 口服疫苗

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US6350457B1 (en) * 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
CN1602199B (zh) 2001-12-11 2012-04-04 巴斯德研究院 用于治疗包含免疫失调的疾病的革兰氏阳性菌制剂
CA2531261A1 (en) 2005-12-21 2007-06-21 Institut Pasteur Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
EP1916000A1 (en) * 2006-10-26 2008-04-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of measles virus nucleoprotein for treating atherosclerosis
EP2087898A1 (en) * 2008-02-06 2009-08-12 Institut Pasteur A preparation of mycobacterium bovis BCG killed by extended freeze drying (EFD) for treating rheumatoid arthritis

Similar Documents

Publication Publication Date Title
JP2013501775A5 (enExample)
Amalaradjou et al. Modern approaches in probiotics research to control foodborne pathogens
WO2015171899A1 (en) Compositions and methods for treating skin and mucous membrane diseases
RU2018106510A (ru) Композиция молочнокислых бактерий для применения в лечении инфекций, обусловленных Propionibacterium acnes, и, в частности, акне
CN105420111A (zh) 一种提高植物乳杆菌冻干存活率的复合保护剂及其制备方法
ES2682670T3 (es) Lisinas de bacteriófagos de Streptococcus para la detección y tratamiento de bacterias gram positivas
SI3023415T1 (en) Histone demethylase inhibitors
JP2013079270A5 (enExample)
RU2015143406A (ru) Способ получения частично очищенных внеклеточных продуктов метаболизма bacillus coagulans и их биологические применения
JP2009526751A5 (enExample)
RU2018121036A (ru) Комбинированная пре- и пробиотическая композиция
WO2011028057A3 (en) Novel bacteriophage and antibacterial composition comprising the same
JP2015510943A5 (enExample)
JP2014500263A5 (enExample)
CN103961283A (zh) 一种祛痘修复冻干制剂及其制备与应用
PH12018500969A1 (en) Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
RU2012134407A (ru) Способ приготовления биомассы, содержащей плантарицин, и ее применение в медицинских целях
JP2015522054A (ja) P.アクネスに対する抗バイオフィルム剤としてのギンバイカ抽出物の使用
CN107535688A (zh) 一种植物源家禽饲料抗菌添加剂及其制备方法
JP2019156793A5 (enExample)
JP2015526463A5 (enExample)
CN102150925A (zh) 一种乳酸菌发酵的抑菌剂及其制备方法
JP2009520810A5 (enExample)
CN107568452B (zh) 一种植物源家畜饲料抗菌添加剂及其制备方法
CN104450579A (zh) 一种用于南美白对虾生态养殖的微生物制剂及其制备方法